Skip to main content
. Author manuscript; available in PMC: 2019 Aug 22.
Published in final edited form as: Nat Med. 2017 Dec 7;23(12):1399–1400. doi: 10.1038/nm.4454

Figure 1.

Figure 1

Organoid models of liver cancer. Broutier et al.5 generated tumor organoids, termed tumoroids, from liver cancer tumor biopsies spanning a range of histological types. Screening of these organoids identified a small-molecule ERK1/2 inhibitor as a potential liver cancer therapeutic and also identified potential prognostic biomarkers.